Celiac Disease: On the Horizon A Livestream International Symposium

A scientific program designed for those interested in the development of non-dietary therapies for celiac disease including adult and pediatric physicians, dietitians and nutritionists, scientists, industry (pharmaceutical, diagnostic, biotechnology and food and agriculture), investor/venture capitalists and patients.

Agenda

Thursday, May 1

7:30 AM - 7:45 AM

Welcoming Remarks

Peter HR Green, MD -- USA

7:45 AM - 8:05 AM

What is non-celiac gluten/wheat sensitivity?

Maria Ines Pinto Sanchez, MD -- USA

8:05 AM - 8:25 AM

Serological Screening for Celiac Disease

Knut Lundin, MD, PhD -- Norway

8:25 AM - 8:45 AM

Avoidant/Restrictive Food Intake Disorder and the gluten-free diet

Jessica Lebovits, RD, CDN -- USA

8:45 AM - 9:05 AM

Child-parent-physician dynamics when treating celiac disease

Ritu Verma, MD -- USA

9:05 AM - 9:25 AM

Microscopic colitis, IBD, and their relationship with celiac disease

Suneeta Krishnareddy, MD -- USA

9:25 AM - 9:45 AM

Celiac disease and college

Randi Wolf, PhD, MPH and Adriana Carrieri -- USA

9:45 AM - 10:00 AM

Discussion

Moderated by Anne Lee, EdD, RDN, LD -- USA

10:00 AM - 10:20 AM

The ebb and flow of celiac disease drug development in the years to come

Chaitan Khosla, PhD -- USA

10:20 AM - 10:40 AM

Tofacitinib in refractory celiac disease

Gerhard Bouma, MD, PhD -- Netherlands

10:40 AM - 11:00 AM

JAK inhibitors in dermatology and celiac disease

Lindsey Bordone, MD -- USA

11:00 AM - 11:20 AM

Gluten digestion, TAK-062 update

Daniel Leffler, MD, MS -- USA

11:20 AM - 11:40 AM

Induction of tolerance, TAK-101 update

Steve Miller, MD -- USA

11:40 AM - 12:00 PM

Inhibiting TTG, TAK-227 update

Detlef Schuppan, MD -- Germany

12:00 PM - 12:15 PM

Discussion

Narrated by Benjamin Lebwohl, MD -- USA

12:15 PM - 1:00 PM

Break

1:00 PM - 1:20 PM

Amlitelimab in Celiac Disease

Alberta Wang, MD, MS -- USA

1:20 PM - 1:40 PM

Anti-HLA-DQ2.5/gluten peptide complexes antibody, DONQ52 update Kosuke Yamashita

Kosuke Yamashita -- Japan

1:40 PM - 2:00 PM

Anti IL15, TEV-53408 update

Michael Fettel, MD -- USA

2:00 PM - 2:20 PM

Latiglutenase: what we’ve learned and next steps

Jack Syage, PhD -- USA

2:20 PM - 2:40 PM

Discussion

Moderated by Peter HR Green, MD -- USA

2:40 PM - 3:00 PM

Break

3:00 PM - 3:15 PM

Skipping the biopsy in adults and children

Stephanie Moleski, MD -- USA

3:15 PM - 3:30 PM

In vitro diagnosis of celiac disease: progress and challenges

Robert Anderson, MD, PhD -- Australia

3:30 PM - 3:45 PM

Can we rely on serologies?

Claire Jansson-Knodell, MD -- USA

3:45 PM - 4:00 PM

“Gluten: what is too much?”

Jennifer Sealey-Voyksner, PhD -- USA

4:00 PM - 4:15 PM

Patients’ perspective on serologies, biopsy, and what it means to have a confirmed diagnosis

Vanessa Weisbrod -- USA

4:15 PM - 4:30 PM

Discussion

Moderated by Jacqueline Jossen, MD -- USA

4:30 PM - 4:45 PM

Navigating complex cases

Peter HR Green, MD -- USA

4:45 PM - 5:00 PM

Follow-up of celiac disease in children

Valentina Discepolo, MD, PhD -- Italy

5:00 PM - 5:15 PM

The current and future role of gluten immunogenic peptide monitoring

Alfonso Rodriquez Herrera, MD, PhD -- Ireland

5:15 PM - 5:30 PM

Does smoking influence the course of celiac disease

Jonas Zeitz, MD -- Switzerland

5:30 PM - 5:45 PM

Follow-up biopsy: why, when, and how often?

Benjamin Lebwohl, MD, MS -- USA

5:45 PM - 6:00 PM

Discussion and wrap-up

Moderated by Suzanne Lewis, MD -- USA

6:00 PM - 6:30 PM

Who will look after all these patients?

Peter HR Green, MD, Knut Lundin, MD, Ritu Verma, MD

Friday, May 2

7:45 AM - 7:50 AM

Introduction

Peter HR Green, MD -- USA

7:50 AM - 8:05 AM

Celiac Disease Incidence and Prevalence Around the World

Govind Makharia, MD -- India

8:05 AM - 8:20 AM

Screening for celiac disease in Italy

Carlo Catassi, MD, MPH -- Italy

8:20 AM - 8:35 AM

Screening for celiac disease in the United States now and in the future

Marisa Stahl, MD -- USA

8:35 AM - 8:50 AM

Discussion

Moderated by Peter HR Green, MD -- USA

8:50 AM - 9:05 AM

Undiagnosed celiac disease: natural history and implications

Joseph Murray, MD -- USA

9:05 AM - 9:20 AM

Celiac disease in Hispanic Americans

Amelie Therrien, MD -- USA

9:20 AM - 9:35 AM

Non-celiac gluten sensitivity: how common is it, and what are the next steps?

Armin Alaedini, PhD -- USA

9:35 AM - 9:50 AM

Environmental risk factors for celiac disease

Jonas Ludvigsson, MD

9:50 AM - 10:05 AM

Case finding approaches to celiac disease

Carol Semrad, MD -- USA

10:05 AM - 10:20 AM

New developments in refractory celiac disease?

Christophe Cellier, MD -- France

10:20 AM - 10:35 AM

Discussion

Moderated by Joseph Murray, MD -- USA

10:35 AM - 10:50 AM

Break

10:50 AM - 11:05 AM

Immunopathogenesis of celiac disease

Joseph Murray, MD -- USA

11:05 AM - 11:20 AM

Involvement of gut luminal transglutaminase in the pathogenesis of celiac disease

Ludvig Sollid, MD, PhD -- Norway

11:20 AM - 11:35 AM

What can we learn from “All of Us”?

Xiao-Fei Kong, MD, PhD -- USA

11:35 AM - 11:50 AM

Pathology of refractory celiac disease

Govind Bhagat, MD -- USA

11:50 AM - 12:05 PM

Discussion

Moderated by Arnold Han, MD -- USA

12:05 PM - 1:00 PM

Break

1:00 PM - 1:15 PM

The microbiome as a risk factor for celiac disease

Maureen Leonard, MD -- USA

1:15 PM - 1:30 PM

Drugs for kids with celiac disease

Jacqueline Jossen, MD -- USA

1:30 PM - 1:45 PM

How can we predict the development of celiac disease

Renata Auricchio, MD, PhD -- Italy

1:45 PM - 2:00 PM

What should we advise parents today regarding how to reduce the risk of their children developing celiac disease

Riccardo Troncone, MD -- Italy

2:00 PM - 2:15 PM

The diverse roles of immune cells in celiac disease

Jocelyn Silvester, MD -- USA

2:15 PM - 2:30 PM

Discussion

Moderated by Jacqueline Jossen, MD -- USA

2:30 PM - 2:45 PM

Wrap-Up

Benjamin Lebwohl, MD -- USA